Glycosidic Tn-based vaccines targeting dermal dendritic cells favor germinal center B-cell development and potent antibody response in the absence of adjuvant.

Source:http://linkedlifedata.com/resource/pubmed/id/20720186

Blood 2010 Nov 4 116 18 3526-36

Download in:

View as

General Info

PMID
20720186